You have a type of ovarian cancer that’s fueled by estrogen. Your cancer has other specific molecular characteristics like biomarkers that are associated with good responses to aromatase inhibitors.

Ovarian cysts are very common in people who menstruate, with an estimated 10% to 30% of women — and potentially more — ...

Dr. Claire Thompson, a Consultant Gynaecological Oncologist at the Mater Misericordiae University Hospital and Rotunda ...

Hormone replacement therapy (HRT) is a standard approach to menopause symptom management. However, some people have concerns about a potential link between HRT and ovarian cancer. While HRT can ...

Tamoxifen is hormone-modifying drug that doctors may prescribe to people with ovarian cancer. It blocks the activity of a hormone called estrogen. Learn more here.

Despite the fact that hormone therapy for menopausal symptoms has been approved in the U.S. since 1943, its influence on endometrial and ovarian cancer incidence and mortality remains unsettled ...

Sometimes also called ovarian estrogen, the secretion of estrogen "begins around the time of puberty" and continues throughout reproductive life − "puberty to menopause," says Cynthia Stuenkel ...

For patients with ovarian and endometrial cancer, receiving conjugated equine estrogen (CEE; a drug that includes estrogen hormones to treat menopause symptoms) alone was associated with significantly ...

Hormone therapy (also called hormonal therapy or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering ...

Results: Our data reveals that MSLN CAR-T cells exhibit a significant upregulation of CD39 upon activation by ovarian cancer cells in both in vitro and in the tumor microenvironment (TME). To assess ...